We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
EZZ Life Science is a biotechnology business based in Australia. EZZ Life Science shares (EZZ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. EZZ Life Science has a trailing 12-month revenue of around $15.9 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
| 52-week range | $0.27 - $0.5896 |
|---|---|
| 50-day moving average | $0.3378 |
| 200-day moving average | $0.4338 |
| Target price | N/A |
| PE ratio | 13.4783 |
| Dividend yield | $0.004 (1.5%) |
| Earnings per share (TTM) | $0.023 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.295
| 1 week (2022-06-17) | -1.67% |
|---|---|
| 1 month (2022-05-27) | -1.67% |
| 3 months (2022-03-28) | -26.25% |
| 6 months (2021-12-24) | -45.37% |
| 1 year (2021-06-28) | -37.23% |
|---|
Valuing EZZ Life Science stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of EZZ Life Science's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
EZZ Life Science's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, EZZ Life Science shares trade at around 13x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
EZZ Life Science's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 million (£672,846).
The EBITDA is a measure of a EZZ Life Science's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $15.9 million |
|---|---|
| Operating margin TTM | 7.41% |
| Gross profit TTM | $12.5 million |
| Return on assets TTM | 8.16% |
| Return on equity TTM | 13.27% |
| Profit margin | 5.69% |
| Book value | 0.235 |
| Market capitalisation | $13 million |
TTM: trailing 12 months
Dividend payout ratio: 22.5% of net profits
Recently EZZ Life Science has paid out, on average, around 22.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.5% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), EZZ Life Science shareholders could enjoy a 1.5% return on their shares, in the form of dividend payments. In EZZ Life Science's case, that would currently equate to about A$0.004 per share.
While EZZ Life Science's payout ratio might seem low, this can signify that EZZ Life Science is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 9 November 2021 (the "ex-dividend date").
EZZ Life Science Holdings Limited provides skin care and consumer health products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned products. It is involved in the wholesale distribution of EAORON branded skin care products to pharmacies, supermarkets, and specialist retailers, as well as grocery retailers. The company also formulates, produces, markets, and sells health supplements under the EZZ brand to retailers and consumers through e-commerce platforms, such as Tmall Global. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silver Water, Australia.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
